NOAEL Studies
Cosmetic Ingredient
HC Violet No. 2 NOAEL Studies
INCI: HC VIOLET NO. 2
CAS: 104226-19-9
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 50 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCP; M.N. Hopkins. Imexine FAG: 13-week oral (gavage) toxicity study in the rat. Toxicol Laboratories, Report N° LRL/80/94, 1995 |
SCCS Opinion 3 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =50 | mg/kg bw/d | - | - | - | NOAEL study | p.14 |
| SCCS Opinion | NOAEL | =2500 | mg/kg bw/d | human | oral | - | NOAEL study | p.20 |
| SCCS Opinion | NOAEL | =50 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.21 |
Regulatory source 4 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | - | 50 | mg/kg bw/d | - | - | - | - | p.14 |
| Regulatory source | - | 2500 | mg/kg bw/d | human | oral | - | - | p.20 |
| Regulatory source | dermal absorption | =50 | mg/kg bw | rat | oral | 90-day | dermal absorption | p.21 |
| Regulatory source | dermal absorption | 50 | mg/kg bw/d | mouse | dermal | - | dermal absorption | p.21 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | 639H4QR04O | UNII | - | - | - | chemical | - |